The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (Review)

Acta Physiologica Hungarica

Volumn 98, Issue 4, 2011, Pages 369-381

  Dongo E ^a   Hornyak I ^a   Benko, Zs ^a   Kiss, Levente ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

cardioprotection; hydrogen sulfide; myocardial ischemia; oxidative stress; reactive oxygen species; reperfusion

Indexed keywords

DNA; HYDROGEN SULFIDE; PROTECTIVE AGENT; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; SODIUM HYDROSULFIDE; SODIUM SULFIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CELL PROTECTION; CONCENTRATION (PARAMETERS); DISEASE MODEL; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; METABOLISM; NITRATION; NONHUMAN; OXIDATION; PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; HUMANS; HYDROGEN SULFIDE; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS;

EID: 84255208945     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.98.2011.4.1     Document Type: Review

References (62)

1. Arikan DC, Bakan V, Kurutas EB, Sayar H, Coskun A: Protective effect of tadalafil on ischemia/reperfusion injury of rat ovary. J. of Pediatric Surgery 45, 2203-2209 (2010)
2. Beauchamp RO, Jr., Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA: A critical review of the literature on hydrogen sulfide toxicity. Crit. Rev. Toxicol. 13, 25-97 (1984) (Pubitemid 14069476)
3. Bhatia M, Zhi L, Zhang H, Ng SW, Moore PK: Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L896-904 (2006) (Pubitemid 44772051)
4. Bian J-S, Yong QC, Pan T-T, Feng Z-N, Ali MY, Zhou S, Moore PK: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. of Pharmacology and Experimental Therapeutics 316, 670-678 (2006) (Pubitemid 43130994)
5. Bliksøen M, Kaljusto M-L, Vaage J, Stensløkken K-O: Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Europ. J. of Cardio-Thoracic Surgery 34, 344-349 (2008)
6. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB: Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J. Clin. Invest. 82, 476-485 (1988)
7. Calvert JW, Coetzee WA, Lefer DJ: Novel insights into hydrogen sulfide mediated cytoprotection. Antioxidants & redox signaling 12, 1203-1217 (2010)
8. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A, Lefer DJ: Genetic, pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122, 11-19 (2010)
9. Chen LY, Nichols WW, Hendricks J, Mehta JL: Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am. Heart J. 129, 211-218 (1995)
10. Chuah SC, Moore PK, Zhu YZ: S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. American Journal of Physiology-Heart and Circulatory Physiology 293, H2693-H2701 (2007) (Pubitemid 350106492)
11. Davies KJ: Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262, 9895-9901 (1987)
12. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655-673 (2000) (Pubitemid 30406736)
13. Elahi MM, Kong YX, Matata BM: Oxidative stress as a mediator of cardiovascular disease. Oxid. Med. Cell Longev. 2, 259-269 (2009)
14. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow C-W, Lefer DJ: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proceedings of the National Academy of Sciences 104, 15560-15565 (2007) (Pubitemid 47502956)
15. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A, Ceconi C, Curello S, Visioli O: Oxidative stress during myocardial ischaemia and heart failure. Eur. Heart J, 19(Suppl B), B2-11 (1998)
16. Girotti AW: Mechanisms of lipid peroxidation. J. Free Radic. Biol. Med. 1, 87-95 (1985) (Pubitemid 16133244)
17. Guidotti TL: Hydrogen sulfide: advances in understanding human toxicity. Int. J. Toxicol 29, 569-581
18. Jewett SL, Eddy LJ, Hochstein P: Is the autoxidation of catecholamines involved in ischemia-reperfusion injury? Free Radic Biol Med, 6, 185-188 (1989) (Pubitemid 19054669)
19. Ji Y, Pang Q-F, Xu G, Wang L, Wang J-K, Zeng Y-M: Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Europ. J. of Pharmacology 587, 1-7 (2008)
20. Johansen D, Ytrehus K, Baxter G: Exogenous hydrogen sulfide protects against regional myocardial ischemia- reperfusion injury. Basic Research in Cardiology 101, 53-60 (2006)
21. Kaneko M, Masuda H, Suzuki H, Matsumoto Y, Kobayashi A, Yamazaki N: Modification of contractile proteins by oxygen free radicals in rat heart. Mol. Cell Biochem. 125, 163-169 (1993) (Pubitemid 23312733)
22. Kiss L, Deitch EA, Szabo C: Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci. 83, 589-594 (2008)
23. Kloner RA, Ellis SG, Lange R, Braunwald E: Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation 68, I8-15 (1983)
24. Kubli H: Die Dissociation von Schwefelwasserstoff. Helv. Chim. Acta, 29, 12 (1946)
25. Kukreja RC, Hess ML: The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res, 26, 641-655 (1992)
26. Lavu M, Bhushan S, Lefer DJ: Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond), 120, 219-229, (2010)
27. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J, 19, 1196-1198 (2005) (Pubitemid 40946463)
28. Li L, Rose P, Moore PK: Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 51, 169-187 (2011)
29. Matsuo Y, Greenberg DM: A crystalline enzyme that cleaves homoserine and cystathionine. J. of Biological Chemistry 234, 507-515 (1959)
30. Minamishima S, Bougaki M, Sips PY, De Yu J, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F: Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120, 888-896 (2009)
31. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N: Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monit. 15, RA209-219 (2009)
32. Nakagawa H KH: Purification and properties of cystathionine synthetase from rat liver: separation of cystathionine synthetase from serine dehydratase. Biochem. Biophys. Res. Commun. 32, 5 (1968)
33. Napoli C, de Nigris F, Palinski W: Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82, 674-682 (2001) (Pubitemid 32720682)
34. Osipov RM, Robich MP, Feng J, Liu Y, Clements RT, Glazer HP, Sodha NR, Szabo C, Bianchi C, Sellke FW: Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: Comparison of different administration regimens and characterization of the cellular mechanisms of protection. J. of Cardiovasc. Pharmacol. 54, 287-297 (2009)
35. 2S preconditioning and post-infarction treatment. Europ. J. of Pharmacology 616, 160-165 (2009)
36. Pan T-T, Feng Z-N, Lee SW, Moore PK, Bian J-S: Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. Journal of Molecular and Cellular Cardiology 40, 119-130 (2006) (Pubitemid 43012123)
37. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am. J. of Physiol. Cell Physiology 294, C169-C177 (2008)
38. Prasad K, Lee P, Mantha SV, Kalra J, Prasad M, Gupta JB: Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence. Mol. Cell Biochem. 115, 49-58 (1992)
39. Quarrie R, Cramer BM, Lee DS, Steinbaugh GE, Erdahl W, Pfeiffer DR, Zweier JL, Crestanello JA: Ischemic preconditioning decreases mitochondrial proton leak and reactive oxygen species production in the postischemic heart1. The Journal of Surgical Research 165, 5-14
40. Reiffenstein RJ, Hulbert WC, Roth SH: Toxicology of hydrogen sulfide. Annu. Rev. Pharmacol. Toxicol. 32, 109-134 (1992)
41. Schmidt A, Erdle I, Gamon B: Isolation and characterization of thiosulfate reductases from the green alga Chlorella fusca. Planta 162, 7 (1984)
42. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31, 267-274 (2009)
43. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Sellke FW: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Europ. J. of Cardio-Thoracic Surgery 33, 906-913 (2008)
44. Stipanuk MH, Beck PW: Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J, 206, 267-277 (1982)
45. Suleimenov OMK, Krupp RE: Solubility of hydrogen sulfide in pure water and in NaCl solutions, from 20 to 320 °C and at saturation pressures. Geochim. Cosmochim. Acta 58, 2 (1994)
46. Sun W, Nesic S, Young D: Equilibrium expressions related to the solubility of the sour corrosion product mackinawite. Ind. Eng. Chem. Res. 47, 5 (2008)
47. Szabo C: Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917-935 (2007) (Pubitemid 350042399)
48. Szabo G, Veres G, Radovits T, Gero D, Modis K, Miesel-Groschel C, Horkay F, Karck M, Szabo C: Cardioprotective effects of hydrogen sulfide. Nitric Oxide (2010)
49. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van Der Wall EE, Bassand J-P, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon J-L, Pais P, Mendis S, Zhu J-R, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio- Pulkki L-M, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N: Universal definition of myocardial infarction. Europ. Heart J. 28, 2525-2538 (2007) (Pubitemid 47616190)
50. Tolosa EA CN, Khomutov RM, Severin ES: Reactions catalysed by cysteine lyase from the yolk sac of chicken embryo. Biochim. Biophys. Acta 171, 3 (1969)
51. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, Zagli G, Creminon C, Geppetti P, Harrison S: Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. 145, 1123-1131 (2005) (Pubitemid 43079985)
52. Tsutsui H, Kinugawa S, Matsushima S: Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc. Res. 81, 449-456 (2009)
53. Uhteg LC WJ: Purification and steady-state kinetic analysis of yeast thiosulfate reductase. Arch. Biochem. Biophys. 195, 12 (1979)
54. Warenycia MW, Smith KA, Blashko CS, Kombian SB, Reiffenstein RJ: Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels. Arch. Toxicol. 63, 131-136 (1989) (Pubitemid 19107372)
55. Wei H, Zhang R, Jin H, Liu D, Tang X, Tang C, Du J: Hydrogen sulfide attenuates hyperhomocysteinemiainduced cardiomyocytic endoplasmic reticulum stress in rats. Antioxidants & Redox Signaling 12, 1079-1091 (2010)
56. Whiteman M MPK: Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J. Cell. Mol. Med. 13, 21 (2009)
57. Woodall GM, Smith RL, Granville GC: Proceedings of the Hydrogen Sulfide Health Research and Risk Assessment Symposium October 31-November 2, 2000. Inhal. Toxicol. 17, 593-639 (2005) (Pubitemid 41161313)
58. Yao L-L, Huang X-W, Wang Y-G, Cao Y-X, Zhang C-C, Zhu Y-C: Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. American Journal of Physiology-Heart and Circulatory Physiology 298, H1310-H1319 (2010)
59. Zhang Z, Huang H, Tang C, Wang J: Hydrogen sulfide contributes to cardioprotection during ischemia- reperfusion injury by opening K-ATP channels. Canadian J. of Physiol. and Pharmacol. 85, 1248-1253 (2007) (Pubitemid 351196401)
60. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH, Tan CS, Whiteman M, Lu J, Moore PK: Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J. of Appl. Physiol. 102, 261-268 (2007) (Pubitemid 46089775)
61. Zhuo Y, Chen P-F, Zhang A-Z, Zhong H, Chen C-Q, Zhu Y-Z: Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of surviving gene. Biological & Pharmaceutical Bulletin 32, 1406-1410 (2009)
62. Zweier JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl. Acad. Sci U S A 84, 1404-1407 (1987) (Pubitemid 17027362)